North America and Europe Fast Melt Tablets Market
- 2026 年市場規模
- USD 3,398.0 Mn
- 2033 年預估規模
- USD 5,222.3 Mn
- 年複合成長率 CAGR
- 6.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
North America and Europe Fast Melt Tablets Market, By Drug Class (Antipsychotics, Proton Pump Inhibitors, Anticonvulsant, Antidepressant, and Others), By Disease Indication (Schizophrenia, Allergy, Parkinsons Disease, Migraine, Major Depressive Disorder (MDD), and Others), By Age Group (Pediatrics, Adults, and Geriatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America and Europe)
報告摘要
The North America and Europe fast melt tablets market is estimated to be valued at USD 3,398.0 Mn in 2026 and is expected to reach USD 5,222.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033. Fast melt tablets, commonly referred to as orally disintegrating tablets (ODTs), are solid oral dosage forms which disintegrate in the oral cavity on contact with saliva within the short span of 30-60 seconds without the need of water. These tablets enhance the adherence of medication to patients, specifically the pediatric and geriatric populations as well as the patients suffering from the problem of swallowing. The fast melt tablet formulation can be effectively utilized by utilizing lyophilization or direct compression technologies to obtain rapidly dissolving and stable drugs with enhanced absorption characteristics.
North America and Europe fast melt tablets market is steadily growing, as a result of rising demand for convenient and effective drug delivery system along with growing initiatives and initiatives in countries such as the U.S., Canada, and Europe. The demand for fast melt tablets is witnessed across therapeutic indications like central nervous system (CNS) disorders, cardiovascular diseases, allergies and respiratory conditions, gastrointestinal (GI) disorders, pain and analgesics and migraine, reflecting the expanding adoption of fast melt formulations in both prescription and over-the-counter medicines.
Market Dynamics
The North America and Europe fast melt tablets market is primarily driven by growing prevalence of chronic disorders, increased demand for convenient drug delivery systems among the target population, and rising elderly and pediatric populations benefiting from easy administration options. Growing R&D activities, improvements in the freeze-drying process and direct compression, and U.S.FDA/EMA guidance pertaining to their acceptance as oral dosage forms (both in prescription as well as OTC drugs) are pushing for higher acceptance of fast melt tablets.
Nonetheless, there are some challenges faced by the market such as, increased cost of manufacturing of fast melt tablet, requirements of the specialized packaging and product instability and vulnerability to mechanical stress and humidity. Nevertheless, technological innovations (3D printing and Nanotechnology), 3D Printed and nanotechnology-based formulation and growth of telehealth & online pharmacy market will offer new opportunities for growth in North America and Europe fast melt tablets market.
Key Features of the Study
• This report provides in-depth analysis of the North America and Europe fast melt tablets market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the North America and Europe fast melt tablets market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca PLC, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd., and Sun Pharmaceutical Industries Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The North America and Europe fast melt tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America and Europe fast melt tablets market
Market Segmentation
• Drug Class Insights (Revenue, USD Mn, 2021 - 2033)
o Antipsychotics
o Proton Pump Inhibitors
o Anticonvulsant
o Antidepressant
o Others
• Disease Indication Insights (Revenue, USD Mn, 2021 - 2033)
o Schizophrenia
o Allergy
o Parkinson’s Disease
o Migraine
o Major Depressive Disorder (MDD)
o Others
• Age Group Insights (Revenue, USD Mn, 2021 - 2033)
o Pediatrics
o Adults
o Geriatrics
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Key Players Insights
o Pfizer Inc.
o Teva Pharmaceutical Industries Ltd.
o Novartis AG
o AstraZeneca PLC
o Merck & Co., Inc.
o GlaxoSmithKline plc
o Johnson & Johnson
o Bausch Health Companies Inc.
o Reddy's Laboratories Ltd.
o Sun Pharmaceutical Industries Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o AReport Description
Market Definition and Scope
o Executive Summary
North America and Europe Fast Melt Tablets Market, By Drug Class
North America and Europe Fast Melt Tablets Market, By Disease Indication
North America and Europe Fast Melt Tablets Market, By Age Group
North America and Europe Fast Melt Tablets Market, By Distribution Channel
North America and Europe Fast Melt Tablets Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. North America and Europe Fast Melt Tablets Market, By Drug Class, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Antipsychotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Proton Pump Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Anticonvulsant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antidepressant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. North America and Europe Fast Melt Tablets Market, By Disease Indication, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Schizophrenia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Allergy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Parkinson’s Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Migraine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Major Depressive Disorder (MDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. North America and Europe Fast Melt Tablets Market, By Age Group, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pediatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Geriatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. North America and Europe Fast Melt Tablets Market, By Distribution Channel, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. North America and Europe Fast Melt Tablets Market, By Region, 2021-2033, (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Europe
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
9. Competitive Landscape
o Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o AstraZeneca PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bausch Health Companies Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Reddy's Laboratories Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Fast Melt Tablets Market’– North America and Europe forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們